Physician

Luke Michael Huerter, M.D.

According to 2025 Medicare claims, Luke Huerter, M.D. (NPI: 1861679276) practices hematology/oncology in the Lawrence, KS market, with the plurality of this provider's patient population coming from Douglas, KS. This provider's primary affiliated billing organization is LAWRENCE PHYSICIANS LLC (NPI: 1962819102; TIN: 471216616) and primary practice location at 66044-1360.

Huerter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 460 traditional Medicare patients, billed 2,006 HCPCS/CPT codes, and received $137,696 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,380 prescription claims across 212 beneficiaries totaling $2,021,984 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 27 claims. Open Payments data shows 2 records totaling $118. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $52,589 to $137,696. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $564,323 to $2,021,984. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	340	1,088	$52,589
2016	340	1,103	$49,375
2017	372	1,132	$58,038
2018	368	1,165	$62,825
2019	356	969	$51,280
2020	359	1,115	$59,985
2021	425	1,504	$109,547
2022	421	1,551	$114,845
2023	465	1,805	$138,311
2024	460	2,006	$137,696

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	124	716	$564,323
2016	127	763	$496,449
2017	141	842	$948,692
2018	148	1,018	$1,486,970
2019	136	848	$1,309,832
2020	138	850	$1,105,538
2021	185	1,029	$820,940
2022	196	1,306	$1,431,940
2023	211	1,345	$1,035,893
2024	212	1,380	$2,021,984

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	60	$6,384
2017	N/R	22	$3,645
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$2,565
2021	N/R	N/R	N/R
2022	N/R	31	$331
2023	N/R	28	$340
2024	N/R	27	$345

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	169	437	$107
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	43	50	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	323	877	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	55	130	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	190	376	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	24	720	$372,437
Venclexta	Venetoclax	16	480	$226,373
Lenalidomide	Lenalidomide	15	413	$211,049
Eliquis	Apixaban	88	4,070	$78,853
Xarelto	Rivaroxaban	40	2,497	$45,705

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	15	$282
J8610	Methotrexate; oral, 2.5 mg	N	N/R	12	$63

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$118	SEAGEN INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Luke Michael Huerter, M.D.?

Tedicare shows public-source Medicare data for Luke Michael Huerter, M.D. (NPI 1861679276), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Luke Michael Huerter, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Luke Michael Huerter, M.D.?

Luke Michael Huerter, M.D. is linked to LAWRENCE PHYSICIANS LLC (billing NPI 1962819102) in the available physician profile data.

Does Luke Michael Huerter, M.D. have Open Payments data?

Luke Michael Huerter, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.